September 2, 2020
Vaxess Announces Federal Contract for Development of the MIMIX™ Smart Release Patch Platform
Funding supports design and development of a scaled manufacturing process of the company’s novel vaccine delivery platform as the company advances a single-dose, refrigeration-free COVID-19 + seasonal Influenza protection alternative vaccination technology.
Vaxess Technologies, Inc., was awarded a contract from the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services (HHS), as part of BARDA’s efforts to evaluate alternative vaccination technologies.
[Read the full article here]